Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease

BACKGROUND/AIMS: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with Crohn’s disease (CD) are rare, particularly for Asian patients. We compared the key clinical outcomes (surgery, hospitalization, and corticosteroid use) of use of these two drugs in biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yoon Suk, Han, Minkyung, Park, Sohee, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817934/
https://www.ncbi.nlm.nih.gov/pubmed/32839359
http://dx.doi.org/10.5009/gnl19377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817934/
https://www.ncbi.nlm.nih.gov/pubmed/32839359
http://dx.doi.org/10.5009/gnl19377

Ejemplares similares